SkylineDx is a high-tech commercial stage biotech company headquartered in Rotterdam, the Netherlands and a commercial office and laboratory in San Diego, California, USA.
Specialising in oncology, particularly blood cancers, the company uses its expertise to bridge the gap between academically discovered gene expression signatures and commercially available diagnostic products with high clinical utility. With the focus on diagnostics, SkylineDx assists healthcare professionals in accurately determining the type or status of the disease or to predict a patient’s response to a specific treatment. Based on the test results, healthcare professionals can tailor the treatment to the individual patient.
In addition, it engages in working with academic, pharmaceutical, and industrial partners for the development and commercialisation of companion diagnostics and other tests. SkylineDx B.V. has a strategic collaboration with Mayo Clinic.